P473: DEVELOPMENT OF POTENTIAL BIOMARKERS FOR IRAK4 INHIBITOR EMAVUSERTIB IN HUMAN ACUTE MYELOID LEUKEMIA

• A. Ugolkov,
• M. Pilichowska,
• C.-C. Li,
• R. C. Hok,
• M. Samson,
• M. Lane,
• R. Von Roemeling,
• R. Martell

Affiliations

A. Ugolkov

1 Curis, Inc., Lexington, MA

M. Pilichowska

2 Tufts Medical Center, Boston, MA, United States of America

C.-C. Li

1 Curis, Inc., Lexington, MA

R. C. Hok

1 Curis, Inc., Lexington, MA

M. Samson

1 Curis, Inc., Lexington, MA

M. Lane

1 Curis, Inc., Lexington, MA

R. Von Roemeling

1 Curis, Inc., Lexington, MA

R. Martell

1 Curis, Inc., Lexington, MA